Entry Detail



General Information

Database ID:exR0275267
RNA Name:hsa-miR-1281
RNA Type:miRNA
Chromosome:chr22
Starnd:+
Coordinate:
Start Site(bp):41092545End Site(bp):41092561
External Links:hsa-miR-1281



Disease Information

Disease Name:Advanced Adenoma
Disease Category:Cancers
MeSH ID:D000236
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Adenoma//Adenomas//Adenoma, Follicular//Adenomas, Follicular//Follicular Adenoma//Follicular Adenomas//Adenoma, Trabecular//Adenomas, Trabecular//Trabecular Adenoma//Trabecular Adenomas//Adenoma, Monomorphic//Adenomas, Monomorphic//Monomorphic Adenoma//Monomorphic Adenomas//Adenoma, Papillary//Adenomas, Papillary//Papillary Adenoma//Papillary Adenomas//Adenoma, Basal Cell//Adenomas, Basal Cell//Basal Cell Adenoma//Basal Cell Adenomas//Adenoma, Microcystic//Adenomas, Microcystic//Microcystic Adenoma//Microcystic Adenomas



Expression Detail

GEO ID:GSE25609
Description:Plasma microRNA profiling by microarray elucidates several candidate biomarkers for colorectal cancer screening
Experimental Design:Cancer vs Control
Case Disease Type:Advanced Adenoma
Case Disease SubType:NA
Case Sample:Advanced Adenoma Post surgery
Control Sample:Control
Number of Case:20
Number of Control:20
Number of Samples:40





Regulatory Relationship

mRNA targets:NA
miRNA targets:NA
circRNA targets:NA
lncRNA targets:NA
Display:N/A



Experiment Detail

GEO ID:GSE25609
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL8179
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:826
Sample treatment protocol:Briefly, samples were centrifuged at 1,600×g for 10 min at 4 ºC to spin down blood cells, and plasma was transferred into new tubes, followed by further centrifugation at 16,000×g for 10 minutes at 4ºC to completely remove cellular components.
RNA Extract protocol:NA
RNA library preparation protocol:Biotinylated cDNA were prepared with the Illumina® TotalPrep™ RNA Amplification Kit (Ambion).



Reference

PMID:23267864
Title:Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study
Author:Gir¨¢ldez MD, Lozano JJ, Ram¨ªrez G, Hijona E, Bujanda L, Castells A, Gironella M
Journal:Clin Gastroenterol Hepatol. 2013 Jun;11(6):681-8.e3.
Description:We investigated whether plasma levels of miRNA can differentiate patients with CRC from healthy individuals. We also investigated whether plasma samples from patients with premalignant neoplastic lesions, such as advanced adenomas (AAs), also had a different expression pattern of miRNAs.